“Do No harm” - How Medicare Advantage policies are harming cancer patients

Medicare Advantage began in 2003 as a rebranding of the then-named Medicare Part C. It has since expanded to include most Medicare-eligible patients and is projected to capture 60% of these patients by 2028.1 Its programs promote great benefits and high-value care at low premiums across the board, but recently, numerous organizations have scrutinized these claims. Medicare Advantage operates under the “benchmark-bid” scheme, in which the plan “bids” its estimated cost of care per patient against an average Traditional Medicare patient.
Source: American Journal of Surgery - Category: Surgery Authors: Tags: My Thoughts / My Surgical Practice Source Type: research